Figure 6From: Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection Mean EQ-5D (±SE) changes over time in the Visual Analogue Scale (VAS) by treatment group for patients with and without FSS scores at baseline. Back to article page